Precautions with Pregnancy: How Antidepressants May Affect Fetal Health ft. Dr. Alison Holloway

In this comprehensive video, we delve into the topic of antidepressants during pregnancy. Expecting mothers face a unique set of challenges, and understanding the role of antidepressants is crucial. Join us as we explore the potential risks and benefits associated with these medications.

Dr. Alison Holloway, a distinguished expert in pharmacology, joins us to provide valuable insights. Through her extensive research, Dr. Holloway sheds light on how antidepressants may impact both maternal and fetal health, offering a deeper understanding of this complex topic.
From explaining the mechanism of antidepressants in simple terms to discussing potential side effects, we cover all the essential information. Whether you're a soon-to-be mother, a healthcare professional, or anyone interested in the topic, this video offers valuable knowledge to help navigate this critical aspect of pregnancy.

Acknowledgements: We extend our appreciation to Dr. Holloway a professor at McMaster University. With around 177 published research articles, Dr. Holloway is a leading expert in pharmacology. Her research at McMaster focuses on the effects of various substances, like prescription drugs and caffeine, on the health of pregnant mothers and their babies. Specifically, she investigates the impact of certain antidepressants on maternal and fetal health.

Timestamps
Introduction to Pregnancy and Antidepressants 0:00
Mechanism of SSRIs 1:16
Exploring Side Effects 2:25
Insights from Dr. Holloway's Research 3:23
Takeaways and Conclusion 6:07

#Antidepressants, #Pregnancy, #SSRIs (Selective Serotonin Reuptake Inhibitors), #AlisonHolloway

This video was made by McMaster University students Maryam Qader, Aya Selman, Jenny Lu, and Hanna Tilahun Solomon in collaboration with the Demystifying Medicine McMaster Program.

This video is provided for general and educational information only. Please consult your health care provider for information about your health.

Copyright McMaster University 2024

References:
Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016). Long-term antidepressant use: Patient perspectives of benefits and adverse effects. Patient Preference and Adherence, 10, 1401–1407. https://doi.org/10.2147/PPA.S110632

De Long, N. E., Barry, E. J., Pinelli, C., Wood, G. A., Hardy, D. B., Morrison, K. M., Taylor, V. H., Gerstein, H. C., & Holloway, A. C. (2015). Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats. Toxicology and Applied Pharmacology, 285(1), 32-40. https://doi.org/10.1016/j.taap.2015.0...

InformedHealth.org. (2006). Depression: How effective are antidepressants? Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG). Retrieved June 18, 2020, from https://www.ncbi.nlm.nih.gov/books/NB...

Mayo Clinic. (2019, September 12). Antidepressants: Get tips to cope with side effects. Mayo Clinic. https://www.mayoclinic.org/diseases-c...

Alison Holloway. Alison Holloway - McMaster Experts. (n.d.). https://experts.mcmaster.ca/display/h...

Sudbery, I., Enright, A. J., Fraser, A. G., & Dunham, I. (2010). Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis. BMC genomics, 11, 1-12.